Myositis disease
MONDO:0021167An inflammatory disease involving a pathogenic inflammatory response in the muscle tissue.
Also known as: inflammation of muscle tissue, inflammatory disorder of muscle (disorder), muscle tissue inflammation
299 clinical trials for this condition and its sub-types, 105 tagged with Myositis disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Myositis disease
-
Idiopathic inflammatory myopathy 61 trials · 181 incl. sub-types
2 sub-types
- Acquired idiopathic inflammatory myopathy 67 trials · 159 incl. sub-types Sub-types →
- Familial idiopathic inflammatory myopathy 0 trials
-
Tendinitis 24 trials · 77 incl. sub-types
6 sub-types
- Patellar tendinitis 22 trials
- Tenosynovitis 4 trials · 14 incl. sub-types Sub-types →
- Calcific tendinitis 10 trials
- Achilles bursitis 7 trials
- Tibialis tendinitis 1 trial
- Paratenonitis 0 trials Sub-types →
-
Inclusion body myositis 35 trials · 38 incl. sub-types
2 sub-types
- GNE myopathy 3 trials
- Myopathy, proximal, and ophthalmoplegia 0 trials Sub-types →
-
Myositis ossificans 11 trials
1 sub-type
- Traumatic myositis ossificans 0 trials
-
Myositis fibrosa 1 trial
-
Bacterial myositis 0 trials
1 sub-type
- Pyomyositis 0 trials
-
Fungal myositis 0 trials
-
Idiopathic granulomatous myositis 0 trials
-
Infectious myositis 0 trials
1 sub-type
- Parasitic myositis 0 trials Sub-types →
-
Orbital myositis 0 trials
-
Viral myositis 0 trials
Most studied deeper sub-types
-
Can a targeted immune drug calm rare muscle inflammation?
Disease control CompletedThis trial tests whether efgartigimod, an injected drug that blocks certain immune antibodies, can improve muscle strength and function in adults with active idiopathic inflammatory myopathy — a group of rare autoimmune diseases that cause muscle inflammation and weakness. About …
Phase 2/3 • Sponsor: argenx • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New drug shows promise for rare muscle disease
Disease control CompletedThis study tested an experimental drug called daxdilimab in 12 adults with dermatomyositis or anti-synthetase myositis that wasn't well controlled by standard treatments. The goal was to see if the drug could reduce disease activity and skin symptoms, and help lower steroid use o…
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New drug combo aims to slow lung damage in rare muscle disease
Disease control CompletedThis study tested whether adding nintedanib (OFEV) to standard immunosuppressant therapy can improve symptoms in people with myositis-associated interstitial lung disease, a condition where lung tissue becomes scarred and stiff. 49 adults in the U.S. participated, receiving eithe…
Phase 4 • Sponsor: Rohit Aggarwal, MD • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug ABC008 shows promise in slowing rare muscle disease
Disease control CompletedThis study tested a new drug, ABC008, in 272 adults with inclusion body myositis, a rare muscle-weakening disease. The goal was to see if the drug is safe and can help slow the disease's progression. Participants received either ABC008 or a placebo, and their muscle function was …
Phase 2/3 • Sponsor: Abcuro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental drug shows promise for rare muscle diseases
Disease control CompletedThis study tested the long-term safety and effectiveness of a drug called KZR-616 in 18 adults with active polymyositis or dermatomyositis, rare diseases that cause muscle inflammation and weakness. Participants who completed an earlier study received weekly injections of KZR-616…
Phase 2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental drug KZR-616 tested for rare muscle disorders
Disease control CompletedThis Phase 2 trial tested a drug called KZR-616 (zetomipzomib) in 25 adults with active polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. Participants received either the drug or a placebo for 16 weeks, then switched to the other trea…
Phase 2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
MRI may replace needle biopsy for muscle disease diagnosis
Diagnosis CompletedThis study looked at whether whole body MRI can accurately diagnose inflammatory myopathies—a group of muscle diseases causing weakness and damage. Researchers compared MRI results with muscle biopsies in 139 people suspected of having these conditions. If MRI proves reliable, it…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Robotic leg device shows promise for helping muscle disease patients walk
Symptom relief CompletedThis study tested a powered leg exoskeleton (Keeogo) in 50 people with various muscle disorders to see if it is safe and helps them walk better. Participants performed walking tests with and without the device. The goal was to see if the device could improve walking distance and …
Sponsor: Institut de Myologie, France • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Robotic exoskeleton shows promise for muscle disease patients
Symptom relief CompletedThis study tested a wearable robotic suit called MyoSuit that assists knee and hip movement in people with various muscle disorders. 32 participants used the device to perform walking tests, and researchers checked for safety and any immediate improvements in walking ability. The…
Sponsor: Institut de Myologie, France • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Video game rehab boosts muscle power in rare muscle disease
Symptom relief CompletedThis study tested whether a virtual reality-based robot-assisted exercise program helps people with inflammatory myopathy (a muscle disease causing weakness) more than standard physical therapy. 33 adults trained 5 times a week for 4-6 weeks using either robotic devices or standa…
Sponsor: National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Military myositis mystery: could exposures be the trigger?
Knowledge-focused CompletedThis study investigated whether environmental exposures during military service increase the risk of developing myositis, a rare autoimmune disease that attacks muscles. Researchers compared 37 military personnel with and without myositis using questionnaires and blood samples. N…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare inflammatory diseases
Knowledge-focused CompletedThis study follows up to 5,000 people with autoinflammatory diseases (like NOMID, CANDLE, and juvenile dermatomyositis) and their healthy relatives. Researchers will collect medical history, blood samples, and imaging over 2-5 day visits to learn how these diseases work and find …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Twin study seeks clues to rheumatic disease mysteries
Knowledge-focused CompletedThis study looks at families where one sibling has a rheumatic disease (like rheumatoid arthritis or lupus) and the other does not. Researchers compare their blood, genes, and environmental exposures to find clues about why one got sick. Over 1,000 participants are involved, incl…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists hunt for genetic and environmental triggers of rare muscle diseases
Knowledge-focused CompletedThis study looked at 719 people, including patients with autoimmune connective tissue diseases like myositis, their blood relatives, and healthy volunteers. Researchers collected blood samples and medical histories to find genetic and environmental factors that may trigger these …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Tiny study hopes to simplify muscle testing for rare muscle disease
Knowledge-focused CompletedThis study looked at a new way to measure muscle function in people with inflammatory myopathies (diseases that cause muscle weakness). Researchers compared a simple test called the Myositis Functional Index-3 with advanced computerised muscle testing. They also tested whether a …
Sponsor: Federal University of Espirito Santo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC